IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia.
IL1RAP 是正常核型三突变急性髓系白血病的免疫治疗靶点
期刊:Biomarker Research
影响因子:11.5
doi:10.1186/s40364-025-00769-z
Métois Arnaud, Bordeleau Marie-Eve, Theret Louis, Hajmirza Azadeh, Moujaber Ossama, Spinella Jean-François, Chagraoui Jalila, Mayotte Nadine, Boivin Isabel, Audemard Ãric, Aubert Léo, Lisi Véronique, Khakipoor Banafsheh, Farah Azer, Bonneil Ãric, Robert Alma, Lippens Julie, Moraitis Anna, Béliveau François, Feghaly Albert, Boucher Geneviève, Marcotte Richard, Gendron Patrick, Thibault Pierre, Lemieux Sébastien, Richard-Carpentier Guillaume, Lavallée Vincent-Philippe, Hébert Josée, Roux Philippe P, Sauvageau Guy